These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32978054)

  • 1. Irreversible Electroporation for Hepatic Tumors: Protocol Standardization Using the Modified Delphi Technique.
    Ruarus AH; Barabasch A; Catalano O; Leen E; Narayanan G; Nilsson A; Padia SA; Wiggermann P; Scheffer HJ; Meijerink MR
    J Vasc Interv Radiol; 2020 Nov; 31(11):1765-1771.e15. PubMed ID: 32978054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus Guidelines of Irreversible Electroporation for Pancreatic Tumors: Protocol Standardization Using the Modified Delphi Technique.
    Vos DJW; Ruarus AH; Timmer FEF; Geboers B; Bagla S; Belfiore G; Besselink MG; Leen E; Martin Ii RCG; Narayanan G; Nilsson A; Paiella S; Weintraub JL; Wiggermann P; Scheffer HJ; Meijerink MR
    Semin Intervent Radiol; 2024 Apr; 41(2):176-219. PubMed ID: 38993594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaesthetic management during open and percutaneous irreversible electroporation.
    Nielsen K; Scheffer HJ; Vieveen JM; van Tilborg AA; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR; Bouwman RA
    Br J Anaesth; 2014 Dec; 113(6):985-92. PubMed ID: 25173767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible Electroporation for Colorectal Liver Metastases.
    Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
    Dunki-Jacobs EM; Philips P; Martin RC
    Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
    Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
    J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
    Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y
    J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
    Dollinger M; Zeman F; Niessen C; Lang SA; Beyer LP; Müller M; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers.
    Jarm T; Krmac T; Magjarevic R; Kos B; Cindric H; Miklavcic D
    Biomed Eng Online; 2020 Nov; 19(1):85. PubMed ID: 33198769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures.
    Cannon R; Ellis S; Hayes D; Narayanan G; Martin RC
    J Surg Oncol; 2013 Apr; 107(5):544-9. PubMed ID: 23090720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Meijerink MR; Ruarus AH; Vroomen LGPH; Puijk RS; Geboers B; Nieuwenhuizen S; van den Bemd BAT; Nielsen K; de Vries JJJ; van Lienden KP; Lissenberg-Witte BI; van den Tol MP; Scheffer HJ
    Radiology; 2021 May; 299(2):470-480. PubMed ID: 33724066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
    Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
    Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac synchronization and arrhythmia during irreversible electroporation.
    O'Neill CH; Martin RCG
    J Surg Oncol; 2020 Sep; 122(3):407-411. PubMed ID: 32483842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Hepatic Lesions After non-Thermal Tumor Ablation by Irreversible Electroporation in a Pig Model.
    Jeon SM; Davaa E; Jiang Y; Jenjob R; Truong NT; Shin KJ; Jeong S; Yang SG
    Technol Cancer Res Treat; 2023; 22():15330338221147122. PubMed ID: 37861099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible electroporation in primary and metastatic hepatic malignancies: A review.
    Lyu T; Wang X; Su Z; Shangguan J; Sun C; Figini M; Wang J; Yaghmai V; Larson AC; Zhang Z
    Medicine (Baltimore); 2017 Apr; 96(17):e6386. PubMed ID: 28445252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis.
    Cheng RG; Bhattacharya R; Yeh MM; Padia SA
    J Vasc Interv Radiol; 2015 Aug; 26(8):1184-8. PubMed ID: 26119204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
    Dollinger M; Jung EM; Beyer L; Niessen C; Scheer F; Müller-Wille R; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
    Simmerman E; Chung J; Lawson A; Kruse E
    J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.